These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 30393891

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature.
    Hagen JW, Pugliano-Mauro MA.
    Dermatol Surg; 2018 Apr; 44(4):469-480. PubMed ID: 29315147
    [Abstract] [Full Text] [Related]

  • 3. Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.
    Gong J, Zhu L, Guo Z, Li Y, Zhu W, Li N, Li J.
    PLoS One; 2013 Apr; 8(11):e81487. PubMed ID: 24312308
    [Abstract] [Full Text] [Related]

  • 4. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
    Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD.
    Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
    [Abstract] [Full Text] [Related]

  • 5. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, De Teresa-Galván J, Redondo-Cerezo E.
    World J Gastroenterol; 2013 Aug 14; 19(30):4877-86. PubMed ID: 23946592
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
    Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS.
    Inflamm Bowel Dis; 2013 Jan 14; 19(1):15-22. PubMed ID: 22434610
    [Abstract] [Full Text] [Related]

  • 12. Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
    Narous M, Nugent Z, Singh H, Bernstein CN.
    Inflamm Bowel Dis; 2023 Jul 05; 29(7):1047-1056. PubMed ID: 35929649
    [Abstract] [Full Text] [Related]

  • 13. Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases.
    Solitano V, D'Amico F, Correale C, Peyrin-Biroulet L, Danese S.
    Br Med Bull; 2020 Dec 15; 136(1):107-117. PubMed ID: 33200781
    [Abstract] [Full Text] [Related]

  • 14. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
    Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L, Cesame Study Group.
    Gastroenterology; 2011 Nov 15; 141(5):1621-28.e1-5. PubMed ID: 21708105
    [Abstract] [Full Text] [Related]

  • 15. Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis.
    Zhang Y, Li D, Guo H, Wang W, Li X, Shen S.
    Curr Pharm Des; 2021 Nov 15; 27(19):2317-2324. PubMed ID: 32938343
    [Abstract] [Full Text] [Related]

  • 16. Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis.
    Zhu Z, Mei Z, Guo Y, Wang G, Wu T, Cui X, Huang Z, Zhu Y, Wen D, Song J, He H, Xu W, Cui L, Liu C.
    J Crohns Colitis; 2018 Apr 27; 12(5):546-558. PubMed ID: 29370346
    [Abstract] [Full Text] [Related]

  • 17. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis.
    Jess T, Lopez A, Andersson M, Beaugerie L, Peyrin-Biroulet L.
    Clin Gastroenterol Hepatol; 2014 Nov 27; 12(11):1793-1800.e1. PubMed ID: 24907505
    [Abstract] [Full Text] [Related]

  • 18. Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
    Ranjan MK, Kante B, Vuyyuru SK, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V.
    J Gastroenterol Hepatol; 2022 Aug 27; 37(8):1544-1553. PubMed ID: 35501287
    [Abstract] [Full Text] [Related]

  • 19. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.
    Singh H, Nugent Z, Demers AA, Bernstein CN.
    Gastroenterology; 2011 Nov 27; 141(5):1612-20. PubMed ID: 21806945
    [Abstract] [Full Text] [Related]

  • 20. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
    Chupin A, Perduca V, Meyer A, Bellanger C, Carbonnel F, Dong C.
    Aliment Pharmacol Ther; 2020 Oct 27; 52(8):1289-1297. PubMed ID: 32840893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.